Catapult continues L3 Technology backing
Catapult Venture Managers has led a £1.75m(€2.3m) second round of funding in cholesterol diagnostic firm L3 Technology.
L3 Technology was founded by Anglo Scientific and CLIK, the commercialisation arm of the Science and Technology Facilities Council, in 2004.